Mead ethanolamide
Mead ethanolamide is an endogenous cannabinoid receptor agonist with Kd values of 753 nM and 1810 nM against CB1 and CB2, respectively[1].
Product Specifications
CAS Number
[169232-04-6]
UNSPSC
12352211
Hazard Statement
H225-H319
Target
Cannabinoid Receptor; Endogenous Metabolite
Type
Reference compound
Related Pathways
GPCR/G Protein; Metabolic Enzyme/Protease; Neuronal Signaling
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/mead-ethanolamide.html
Solubility
10 mM in DMSO
Smiles
CCCCCCCC/C=C\C/C=C\C/C=C\CCCC(NCCO)=O
Molecular Formula
C22H39NO2
Molecular Weight
349.55
Precautions
P210-P233-P240-P241-P242-P243-P264-P280-P303+P361+P353-P305+P351+P338-P370+P378-P403+P235-P501
References & Citations
[1]Priller J, et al. Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors. Mol Pharmacol. 1995 Aug;48 (2) :288-92.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CB1; CB2
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15361431 1 Vial
Lentiviral human RAB7B sgRNA gene knockout kit - Lentiviral human RAB7B sgRNA gene knockout kit (25)
Ask
View Details 135915 50 µg
ATP7b (Copper-transporting ATPase 2, Wilson Disease-associated Protein, PWD, WC1, WND) discontinued
Ask
View Details